BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 24642901)

  • 1. Clearance kinetics and matrix binding partners of the receptor for advanced glycation end products.
    Milutinovic PS; Englert JM; Crum LT; Mason NS; Ramsgaard L; Enghild JJ; Sparvero LJ; Lotze MT; Oury TD
    PLoS One; 2014; 9(3):e88259. PubMed ID: 24642901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purification and characterization of mouse soluble receptor for advanced glycation end products (sRAGE).
    Hanford LE; Enghild JJ; Valnickova Z; Petersen SV; Schaefer LM; Schaefer TM; Reinhart TA; Oury TD
    J Biol Chem; 2004 Nov; 279(48):50019-24. PubMed ID: 15381690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. sRAGE induces human monocyte survival and differentiation.
    Wang Y; Wang H; Piper MG; McMaken S; Mo X; Opalek J; Schmidt AM; Marsh CB
    J Immunol; 2010 Aug; 185(3):1822-35. PubMed ID: 20574008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of soluble receptor for advanced glycation end products on endotoxin-induced lung injury.
    Zhang H; Tasaka S; Shiraishi Y; Fukunaga K; Yamada W; Seki H; Ogawa Y; Miyamoto K; Nakano Y; Hasegawa N; Miyasho T; Maruyama I; Ishizaka A
    Am J Respir Crit Care Med; 2008 Aug; 178(4):356-62. PubMed ID: 18535257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble receptor for advanced glycation end products triggers a proinflammatory cytokine cascade via beta2 integrin Mac-1.
    Pullerits R; Brisslert M; Jonsson IM; Tarkowski A
    Arthritis Rheum; 2006 Dec; 54(12):3898-907. PubMed ID: 17133598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of insulin on the soluble receptor for advanced glycation end products (RAGE).
    Lam JK; Wang Y; Shiu SW; Wong Y; Betteridge DJ; Tan KC
    Diabet Med; 2013 Jun; 30(6):702-9. PubMed ID: 23432638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of the receptor for advanced glycation end products system in women with severe preeclampsia.
    Oliver EA; Buhimschi CS; Dulay AT; Baumbusch MA; Abdel-Razeq SS; Lee SY; Zhao G; Jing S; Pettker CM; Buhimschi IA
    J Clin Endocrinol Metab; 2011 Mar; 96(3):689-98. PubMed ID: 21325454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system.
    Hori O; Brett J; Slattery T; Cao R; Zhang J; Chen JX; Nagashima M; Lundh ER; Vijay S; Nitecki D
    J Biol Chem; 1995 Oct; 270(43):25752-61. PubMed ID: 7592757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of chronic hypoxia on RAGE and its soluble forms in lungs and plasma of mice.
    Gopal P; Gosker HR; Theije CC; Eurlings IM; Sell DR; Monnier VM; Reynaert NL
    Biochim Biophys Acta; 2015 May; 1852(5):992-1000. PubMed ID: 25703138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Higher levels of the soluble receptor for advanced glycation end products and lower levels of the extracellular newly identified receptor for advanced glycation end products were associated with lipid-lowering drugs in patients with type 1 diabetes: a comparative cross-sectional study.
    Melin EO; Dereke J; Hillman M
    Lipids Health Dis; 2020 Oct; 19(1):223. PubMed ID: 33054750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble form of receptor for advanced glycation end-products (sRAGE): do sRAGE ligands or anti-sRAGE auto-antibodies interfere with sRAGE quantification?
    Lorenzi R; Grossin N; Lambert M; Daroux M; Adjoutah Z; Flahaut C; Jacolot P; Tessier FJ; Lefranc D; Desremaux P; Dubucquoi S; Boulanger E
    Ann Clin Biochem; 2014 Mar; 51(Pt 2):248-57. PubMed ID: 23982266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetics, role and therapeutic implications of endogenous soluble form of receptor for advanced glycation end products (sRAGE) in diabetes.
    Yamagishi S; Matsui T; Nakamura K
    Curr Drug Targets; 2007 Oct; 8(10):1138-43. PubMed ID: 17979674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcitriol treatment increases serum levels of the soluble receptor of advanced glycation end products in hemodialysis patients with secondary hyperparathyroidism.
    Sung JY; Chung W; Kim AJ; Kim HS; Ro H; Chang JH; Lee HH; Jung JY
    Tohoku J Exp Med; 2013 May; 230(1):59-66. PubMed ID: 23748365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intra-peritoneal sRAGE treatment induces alterations in cellular distribution of CD19(+), CD3 (+) and Mac-1 (+) cells in lymphoid organs and peritoneal cavity.
    Brisslert M; Amu S; Pullerits R
    Cell Tissue Res; 2013 Jan; 351(1):139-48. PubMed ID: 23086479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The receptor for advanced glycation end products (RAGE) and the lung.
    Buckley ST; Ehrhardt C
    J Biomed Biotechnol; 2010; 2010():917108. PubMed ID: 20145712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. sRAGE alleviates neutrophilic asthma by blocking HMGB1/RAGE signalling in airway dendritic cells.
    Zhang F; Su X; Huang G; Xin XF; Cao EH; Shi Y; Song Y
    Sci Rep; 2017 Oct; 7(1):14268. PubMed ID: 29079726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The receptor for advanced glycation end products and acute lung injury/acute respiratory distress syndrome.
    Guo WA; Knight PR; Raghavendran K
    Intensive Care Med; 2012 Oct; 38(10):1588-98. PubMed ID: 22777515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hexameric calgranulin C (S100A12) binds to the receptor for advanced glycated end products (RAGE) using symmetric hydrophobic target-binding patches.
    Xie J; Burz DS; He W; Bronstein IB; Lednev I; Shekhtman A
    J Biol Chem; 2007 Feb; 282(6):4218-31. PubMed ID: 17158877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Receptor for advanced glycation end products is subjected to protein ectodomain shedding by metalloproteinases.
    Zhang L; Bukulin M; Kojro E; Roth A; Metz VV; Fahrenholz F; Nawroth PP; Bierhaus A; Postina R
    J Biol Chem; 2008 Dec; 283(51):35507-16. PubMed ID: 18952609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble receptor for advanced glycation end products (sRAGE) and endogenous secretory RAGE (esRAGE) in amniotic fluid: modulation by infection and inflammation.
    Romero R; Espinoza J; Hassan S; Gotsch F; Kusanovic JP; Avila C; Erez O; Edwin S; Schmidt AM
    J Perinat Med; 2008; 36(5):388-98. PubMed ID: 18593373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.